ArticleMolecular therapy. Oncology2026
Engineered indoleamine 2,3-dioxygenase variant: Oxidative activation of prodrug indole-3-acetic acid against cancer cells for targeted therapy.
Liru Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.